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INTRODUCTION 
Achalasia is an esophageal motility disorder caused by the 
inability of the lower esophageal sphincter (LES) to relax due to 
the degeneration of inhibitory neurons in the myenteric plex-
us.1 Achalasia has an incidence of 1 in 100,000 individuals an-
nually and a prevalence of 10 in 100,000.2 Achalasia has no ep-
idemiologic predilection for any demographic group, affects 
men and women equally, and can occur at any age.3 Symptoms 
are characterized by dysphagia to solid and liquids, regurgita-
tion of food or saliva, substernal chest pain during meals, weight 
loss, aspiration pneumonia, and heartburn.4,5 Esophageal ma-
nometry reveals incomplete or absent relaxation of the LES and 
aperistalsis of the esophageal body.6
Treatments for achalasia primarily focus on dysphagia relief 
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by decreasing the resting pressure in the LES. Treatments cur-
rently available include botulinum toxin (Botox) injections, 
oral pharmacologic therapies with nitrates and calcium chan-
nel blockers, pneumatic dilation (PD), and surgical myoto-
my.7,8 Only PD and surgical myotomy provide sustained re-
sponse. Multiple studies have demonstrated the efficacy of PD 
exceeds 90% but usually requires serial dilations.7,9-11 The most 
severe complication of PD is esophageal perforation with a 
rate of ~2%.12 A review of 39 studies on laparoscopic myoto-
my found symptomatic improvement in a mean of 89% of pa-
tients.7 A randomized controlled trial found that after 2 years 
of follow-up, laparoscopic Heller myotomy (LHM), as com-
pared with pneumatic dilatation, was not associated with su-
perior rates of therapeutic success.13
Peroral endoscopic myotomy (POEM), is an endoscopic pro-
cedure that achieves division of the esophageal circular muscle 
fibers across the esophagogastric junction (EGJ) and into the 
stomach. It is derived from natural orifice transluminal endo-
scopic surgery (NOTES) and advances in endoscopic submu-
cosal dissection (ESD).14 Pasricha et al.15 initially described the 
feasibility of an endoscopic submucosal esophageal myotomy 
in a pig model in 2007 and the technique was subsequently de-
veloped and translated into clinical care by Inoue et al.16 in Ja-
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pan. This paper will focus on the steps require to set up a 
POEM program in a modern endoscopy program as well as 




The evaluation of any patient with suspected achalasia in-
volves a thorough history with focus on frequency, severity, 
and timing of onset of symptoms.17 The Eckardt score has be-
come the standard metric to assess symptomatic outcomes for 
achalasia and incorporates a scale for dysphagia, regurgitation, 
chest pain, and amount of weight loss with higher scores repre-
senting more severe disease.18 Physiological evaluation should 
be performed with esophageal manometry. The introduction 
of high resolution manometry has increased the sensitivity of 
detecting impaired EGJ relaxation and esophageal aperistal-
sis in classic achalasia and also allows for division into subtypes.2 
The diagnosis of achalasia is supported by barium esophagram 
findings including dilation of the esophagus, a narrow EGJ with 
“bird-beak” appearance, aperistalsis, and poor emptying of 
barium.4 Esophagogastroduodenoscopy is a complementary 
test to rule out pseudoachalasia, mechanical obstruction from 
stricture or tumor, determine the degree of esophageal dilation, 
and evaluate for coexistent esophagitis.1
Botox and PD can cause tissue injury at the LES and resul-
tant submucosal fibrosis, which to varying degrees obliterates 
the dissection plane, making POEM more challenging but still 
feasible.19 Sharata et al.20 found no statistically significant dif-
ference in the length of procedure, incidence of intraoperative 
or postoperative complications, or 6 months postoperative me-
dian Eckardt scores in patients undergoing POEM previously 
treated with Botox or PD. Contraindications to POEM include 
severe pulmonary disease, cirrhosis with portal hypertension, 
severe coagulopathy, prior interventions resulting in submu-
cosal fibrosis including ablation therapy and endoscopic mu-
cosal resection, and esophageal or chest irradiation.21,22
 
PREPARATION
Full liquid diet should be instituted for 2 days prior to the 
procedure and nothing by mouth for at least 8 hours. The 
procedure room is organized with the patient on a centrally 
located procedure table with the endoscopist working at the 
head of the bed (Fig. 1). The patient is positioned supine and 
the procedure is performed under general anesthesia with 
positive pressure ventilation. Broad spectrum antibiotics are 




A forward-viewing high definition gastroscope with a 2.8 
mm working channel (GIF-H180; Olympus, Tokyo, Japan) is 
fitted with a 4 mm transparent distal cap attachment (Model 
No. D-201-11804; Olympus). Carbon dioxide (CO2) gas is 
used for insufflation during the procedure with a CO2 insuffla-
tor (UCR; Olympus). A triangle-tip knife (KD-640L; Olym-
pus), hybrid knife T type (ERBE, Erbe Elektromedizin GmbH, 
Tübingen, Germany), or hook knife (KD-620LR; Olympus) 
is used to create an esophageal mucosal incision, dissect the 
submucosal layer, and divide the circular muscle bundles. 
Coagulating forceps (Coagrasper, FD-411QR; Olympus) are 
used to close larger vessels prior to dissection and for hemo-
stasis. For electrocautery, an electrogenerator (ERBE) is used. 
Final closure of the mucosal entry site is accomplished with he-
mostatic clips (Resolution clip; Boston Scientific, Natick, MA, 
USA) or endoscopic suturing (Overstitch Endoscopic Sutur-
ing System; Apollo Endosurgery, Austin, TX, USA).
 
ENDOSCOPIC TECHNIQUE
The esophagus is irrigated significantly until clean. Lavage 
of the esophageal mucosa is performed with gentamicin 80 
mg in 20 cc normal saline. The initial mucosal incision is done 
along the right anterolateral esophagus at the 2 o’clock position, 
approximately 10 cm proximal to the EGJ. This maintains dis-
tance from high risk structures and leads to a straight tunnel 
ending at the lesser curvature at the cardia (Figs. 2, 3).23 A sub-
mucosal injection is performed using 0.9% NaCl and indigo 
carmine to create separation between mucosa and submucosa. 
An ESD knife (Endocut Q, Effect 3) is used to create a 2 cm 
longitudinal mucosal incision to allow entry to the submuco-
sal space. The width of the submucosal tunnel should extend 
to half the circumference of the tubular esophagus. Larger ves-
sels are coagulated with Coagrasper forceps in soft coagula-
Fig. 1. Room setup for conducting peroral endoscopic myotomy.
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tion mode (Effect 5, 80 W). Dissection of the circular muscle 
fibers begins 3 cm distal to the mucosal entry site over a mini-
mum length of 6 cm in the esophagus, and extending 2 cm 
into the cardia. Confirming extension of the submucosal tun-
nel beyond the LES into the cardia via a retroflexed view with 
visualization of blue discoloration of the cardiac mucosa from 
the blue dye used in the submucosal injection is important to 
prevent inadequate myotomy. Lavage of the submucosal tun-
nel with gentamicin 80 mg in 20 cc normal saline is recommend-
ed by Inoue et al.24 The mucosal entry site is then closed with he-
mostatic clips or endoscopic suturing (Figs. 4, 5). At the end of the 
procedure, the endoscope is inserted into the natural lumen 
down to the stomach to confirm smooth passage through the 
EGJ.
POSTOPERATIVE CARE
Following completion of the POEM procedure, all patients 
should be admitted to the hospital for observation. Routine 
labs and a barium esophagram should be performed on post-
operative day 1. Patients should have nothing by mouth until 
the results of the esophagram are reviewed. If there is no evi-
dence of contrast extravasation, patients can begin a clear liquid 
diet for 3 days. Broad spectrum antibiotics should be continued 
postoperatively for a total of 7 days, and can be transitioned 
from intravenous administration to oral route once patients are 
tolerating a liquid diet. Hospital discharge can be anticipated 
48 hours postprocedure, with outpatient follow-up in 2 to 4 
weeks. There are no consensus guidelines for postoperative 
follow-up after POEM. Repeat Eckardt scores, manometry, 
timed barium esophagram, endoscopy, and pH monitoring 
have all been used.17 An Eckardt score ≤3 is considered a clini-
cal success.13,19,25 Despite treatment, patients with achalasia 
have up to a 50-fold increased risk of developing esophageal 
carcinoma compared with the general population, though pres-
ently no endoscopic surveillance guidelines exist.26
Fig. 2. Anterior view of the tunnel during peroral endoscopic my-
otomy.
Fig. 3. Posterior view of the tunnel during peroral endoscopic my-
otomy.
Fig. 4. Tunnel closure with hemoclips. 
Fig. 5. Tunnel closure with endoscopic sutures.
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OUTCOMES
Even with the limitations of small numbers, early experi-
ence, and short term follow-up, POEM has a short term suc-
cess rate of 90%, similar to initial treatment success of LHM.7,27 
Verlaan et al.6 evaluated the effect of POEM on esophagogas-
tric function by comparing Eckardt score, LES pressure, centi-
meters of barium stasis, EGJ distensibility and reflux esophagitis 
before and 3 months after POEM on 10 consecutive patients. 
They found that POEM had a statistically significant improve-
ment in all outcome measurements of esophagogastric func-
tion except reflux esophagitis (6/10 endoscopically seen, only 
3/10 reported reflux symptoms). Swanstrom and colleagues28 
recently published their findings on long term outcomes for 
POEM. They followed 18 POEM patients for a mean follow-
up of 11.4 months and found all 18 patients had dysphagia 
relief with postoperative manometry and timed barium swal-
lows demonstrating significant improvements at 6 months. 
There was significant objective evidence of gastroesophageal 
reflux disease (GERD) postoperatively in 46% of patients. Stav-
ropoulos et al.22 surveyed 16 expert centers with cumulative 
experience of 841 POEMs and found the prevalence of GERD 
in patients post-POEM to be 12%.
 
COMPLICATIONS
Since Inoue et al.16 described his experience on the first se-
ries of 17 patients with achalasia treated by POEM without 
any major complications, a number of investigators have be-
gun to perform POEM and publish their preliminary experi-
ences. The complications of POEM for which to monitor in-
clude delayed bleeding, pneumoperitoneum, pneumothorax, 
mucosal flap perforation, pneumomediastinum, cervical em-
physema, and displacement of transparent cap. Bleeding usu-
ally occurs at the cut muscular edges because of an abundance 
of small blood vessels and collateral circulation in the muscle 
layers of the esophagus.29 Preventative coagulation of suspect-
ed bleeding areas by using hemostatic forceps significantly re-
duces the risk of delayed bleeding. Li and colleagues30 recently 
published a study reporting delayed bleeding in the submu-
cosal tunnel after POEM in 3/428 patients (0.7%). All three cas-
es of delayed bleeding were controlled by endoscopic hemosta-
sis involving Sengstaken-Blakemore tube insertion and/or 
electrocoagulation without the need for surgical intervention 
or blood transfusions. Pneumoperitoneum and pneumotho-
rax can occur due to gas permeation through the longitudinal 
muscle fibers of the esophagus or due to full-thickness dissec-
tion into the peritoneal cavity at the cardia.19 Pneumoperito-
neum is usually asymptomatic and managed conservatively, al-
though use of a Veress needle (Model No. ETH- UV120; Ethicon, 
Bridgewater, NJ, USA) to decompress capnoperitoneum has 
been described.19,23,27 Treatments of cardiac mucosal penetra-
tion vary from observation to closure by hemostatic clips. Li 
et al.31 described two cases of cardiac mucosal penetration 
treated with fibrin sealant when hemostatic clips failed to seal 
the defect. Saxena et al.32 reported the successful use of over-
the-scope clips to close large esophageal mucosal flaps in two 
patients after inability to initially close the mucosal defect with 
standard clips. Ling and colleagues33 describe a 2 cm mucosal 
flap rupture at the lower esophagus. Due to the risk of resteno-
sis, the rupture was sealed with a retrievable nickel-titanium 
stent instead of endoscopic clips. The stent was removed after 
3 weeks when the rupture healed without any further com-
plications. Closure of full thickness esophagotomy has been 
reported using an endoscopic suturing device in both mus-
cular and mucosal layers after completion of endoscopic my-
otomy.34 Pneumomediastinum and cervical emphysema are 
caused by the insufflation of CO2 into the mediastinum during 
the submucosal tunnel dissection and the myotomy. The mus-
cle fibers and adventitia are not a resistant barrier to CO2, 
which diffuses into the mediastinum and up to the neck.35 Pneu-
momediastinum and cervical emphysema are usually self-
limiting and not clinically relevant. The range of pneumome-
diastinum and cervical emphysema in select published series 
ranged from 0% to 55.5%.16,19,25,36,37 CO2 insufflation has been 
stressed by the vast majority of studies to reduce complications. 
Baldaque-Silva et al.38 reported cap retention in the submuco-
sal tunnel when the endoscope was withdrawn from the sub-
mucosal tunnel for mucosal surface assessment. The cap was re-
trieved with an alligator jaw forceps and afterwards the POEM 
was completed successfully. Despite the theoretical risk of infec-
tions, no cases of mediastinitis have been described perhaps due 
to the prophylactic administration of antibiotics before POEM. 




POEM has been performed for esophageal disorders aside 
from classic achalasia. Responses have been described for 
spastic achalasia, nutcracker esophagus, hypertensive LES, 
sigmoid esophagus, and diffuse esophageal spasm.3,16,20,27,39,40 
The procedure has been performed in children as young as 3 
years, though there is very limited data available.37,41-43 Rescue 
POEM has been described for failed surgical myotomy. 
Onimaru and colleagues44 successfully performed POEM pri-
marily using a posterior myotomy axis in 10 patients with failed 
surgical myotomies (eight Heller, two thoracoscopic) who did 
not respond to PD with excellent short term results. Zhou et 
al.29 performed successful rescue POEM in 12 patients after a 
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mean of 11.9 years from failed Heller myotomy. During a mean 
follow-up of 10.4 months, treatment success was achieved in 
11/12 patients (91.7%).
POEM VS. LHM
There is scant data comparing POEM to LHM. Hungness 
and colleagues25 compared perioperative outcomes between 
POEM and LHM in a nonrandomized retrospective study. They 
found similar outcomes between both groups pertaining to 
myotomy lengths, complication rates, length of stay, and pain 
in postanesthesia care unit. The POEM group had shorter op-
eration times and less estimated blood loss. Treatment success 
at median 6 months follow-up was 89% in POEM patients.
 
FUTURE DIRECTIONS
POEM is a technically challenging and time consuming pro-
cedure. Dissection of the submucosal fibers within the esopha-
geal submucosal tunnel is a lengthy and time consuming task. 
Khashab et al.45 recently described the use of a new endo-
scopic gel composed of a proprietary material with tissue dis-
secting properties to help facilitate submucosal “auto-tunnel-
ing” in an animal experiment. The gel was injected into the 
submucosal layer and upon entry into the submucosal space, a 
submucosal tunnel had already formed and no esophageal sub-
mucosal dissection was required. Further tunneling into the gas-
tric cardia was needed in all pigs with a triangle-tip knife. The 
average procedure time, including myotomy, was 28 minutes.
 
INTERNATIONAL EXPERIENCE
Over the past few years, the number of centers performing 
POEM has expanded. A recently published International 
POEM Survey (IPOEMS) reported data from 25 POEM opera-
tors at 16 expert centers with a combined volume of 841 POEM 
procedures. The mean POEM procedure time varied from 45 
to 174 min. The mean myotomy length ranged from 6 to 15 
cm. The centers surveyed perform 8 to 10 cm length myoto-
mies with extension of the myotomy approximately 2 cm into 
the gastric cardia.22
POEM PROGRAM
Establishing a POEM program allows a tertiary center to 
build a comprehensive motility program and broaden the va-
riety of treatments available for esophageal disorders. Initial 
clinical data has demonstrated the effectiveness and safety of 
endoscopic myotomy when performed by experienced opera-
tors. The increasing positive international experience has made 
the need for a training system in POEM more urgent. POEM 
requires skills including good endoscope manipulation, recog-
nition of luminal structures, and knowledge of extraluminal 
structures, particularly vessels, nerves, and mediastinal anato-
my.46 Starting a POEM program can be a difficult task with 
numerous institutional and administrative processes to clear 
in order to be successful. The prior establishment of a NOTES 
program allows for a much simpler segue into developing a 
POEM program. There are five essential prerequisites to start 
a POEM program: recruiting multidisciplinary collaborators, 
institutional support, credentialing board approval, proper train-
ing, and technical/engineering/nursing support.47
Before starting a POEM program, institutional support 
should be obtained for an animal laboratory, protected time to 
train, grant funding, purchase of equipment, and approval of 
credentialing and privileges. Procedures should only be per-
formed in hospitals with available surgical expertise in man-
aging potential complications. A standardized preprocedural 
checklist is advised to ensure all properly needed equipment 
is available. The procedure can be conducted in an endoscop-
ic suite or operating room. Prior to beginning, the endosco-
pist should ensure all necessary equipment is available. Fol-
lowing the procedure, a standardized postprocedure protocol 
should be followed. Outcomes data should be prospectively 
recorded and maintained in a database to enable analysis.
At present, with few experienced POEM practitioners world-
wide, there is no standardized training or credentialing guide-
lines. Initially, it is recommended that the endoscopist observe 
POEM performed by an experienced operator.48 Familiariza-
tion with all necessary equipment for the procedure is of ut-
most importance. The endoscopist should then practice the 
procedure rigorously. Training should encompass set up of 
equipment, followed by training using nonsurvival porcine mod-
els, then training using survival porcine models prior to under-
taking the procedure in humans.46 Training on models helps 
free the cognitive capacity during procedures by allowing indi-
viduals to automate certain components of a procedure by re-
moving the high stakes clinical environment.49 The porcine or-
gan model is an easy, inexpensive and reproducible animal 
model for training. Due to a long esophagus and its close resem-
blance to a human esophagus, the porcine model allows for re-
alistic exposure to the procedure. The disadvantages of the por-
cine model include thinner esophageal layers, different anatomy 
of the gastric cardia, and a softer and less vascular submucosal 
space which allows for easier submucosal dissection with less 
bleeding risk than in a human esophagus.48,49 Cadaver models 
can be used to confirm the results achieved in the animal 
laboratory prior to clinical implementation. The IPOEMS sur-
vey reported that 10 of 16 centers performing POEM received 
preclinical training before human cases.22 However, the centers 
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Table 1. Select Published Case Series of Peroral Endoscopic Myotomy in Humans













Complications Follow-up, mean mo Comments























Pneumoperitoneum (3/10) 0.5 -
von Renteln  
  et al. (2012)19
16 45 
(26–76)




- Full thickness dissection into mediastinum (13),  
  full thickness dissection into peritoneum  
  (9: cutaneous emphysema 6, pneumoperitoneum 8,  
  mucosal perforation 1)
3 Superficial ulcer in gastric  
  cardia on follow-up, EGD  
  2 days post-POEM, 1 distal  
  esophageal ulcer
Swanstrom  
  et al. (2012)28
18 59 
(22–88)






Full thickness esophagotomy (1),  
  mucosal perforations (2), pneumoperitoneum (1),  














- None 8.5 
(1–14)
Three failed POEM due to  
  submucosal fibrosis








- Periprocedure: cutaneous emphysema (27),  
  pneumothorax (3) 
Postoperative: pneumothorax (30), subcutaneous  
  emphysema (66), mediastinal emphysema (35), delayed  
  hemorrhage (1), pleural effusion (58), minor  
  inflammation or segmental atelectasis of the lungs (59),  
  and gas under diaphragm or pneumoperitoneum (47) 
Delayed: stricture (1), dehiscence (1)
-
Costamagna  









- Junctional flap perforation (2),  
  pneumomediastinum (10),  
  cervical emphysema (2)
3 One failed POEM due to  
  fibrotic submucosa in a  





67:94 - - - - Aspiration pneumonia (1), lesser omental inflammation (1), 




von Renteln  
  et al. (2013)52
70 45 
(40.5–48.8)




- Full thickness dissection into mediastinum (48),  
  full thickness dissection into peritoneum (40), mucosal  
  clip dislocation (3), mucosal injury via electrocautery or  
  laceration (3), bleeding (1), cap detached in submucosal  
  tunnel (1), delayed bleeding leading to mediastinal  

















First 18 cases with balloon dilation 
  for tunnel dissection, last 27 cases 
  with T-type hybrid knife.
Two treatment failures under  
  went salvage balloon dilation
Kumta NA et al.
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had very different training, protocols, and training times, and 
some used ex vivo and others live animal models. The median 
number of proctored cases was 2. An experienced proctor 
should be present for the first initial human cases. Kurian and 
colleagues39 collected data from the first consecutive 40 POEM 
procedures on humans at their institution and determined the 
learning curve plateaus at about 20 cases for experienced en-
doscopists evidenced by decrease in length of procedure, vari-
ability in minutes per centimeter of myotomy, and incidence of 
inadvertent mucosotomies. With the growing number of cen-
ters performing POEM, many institutions have started offer-
ing this procedure after strict credentials have been set in place. 
At our institution, credentialing for POEM requires: 1) board 
certification in general thoracic surgery and upper endoscopic 
experience plus performing four POEM cases in a porcine 
model or 1 proctored human case, or 2) board certification in 
gastroenterology with endoscopic privileges in ESD and en-
doscopic retrograde cholangiopancreatography with sphinc-
terotomy plus performing four POEM cases in a porcine model 
or 1 proctored human case.
The clinical team should also get exposure to the training in 
order to understand the technical aspects behind the proce-
dure and ensure optimal results. Team members should be fa-
miliar with endoscopic equipment and instruments, which 
can reduce stress and mental workload during the procedure 
and potentially reduce complications and risks. Obtaining sup-
port from device or endoscopy representatives can be helpful 
in assisting with technical and engineering questions. 
CONCLUSIONS
POEM is an exciting and novel technique in the realm of 
NOTES and ESD using submucosal tunneling to perform an 
endoscopic myotomy for achalasia and other esophageal disor-
ders. The POEM procedure requires a certain degree of skill and 
competency, and should only be carried out by experienced endos-
copists. Emerging technologies that objectively measure EGJ dis-
tensibility such as endoscopic functional luminal imaging probe 
(EndoFLIP) add parameters to determine efficacy of treatment 
for patients.50 The published literature to date has established the 
efficacy of the procedure and the few clinically significant com-
plications have been usually treated conservatively. Table 1 pres-
ents data from select published case series of successful POEM 
procedures in humans so far.16,19,25,27,28,36,37,41,42,51-55 Further data is 
anticipated as more programs are established at tertiary care 
centers and long term follow-up is collected from pre-existing 
studies. Additional refinements in POEM technique are expect-
ed to yield a paradigm shift in the treatment of esophageal dis-























































































































































































































































































































































































































































































































































































396  Clin Endosc 2014;47:389-397
POEM Program
Conflicts of Interest
The authors have no financial conflicts of interest.
REFERENCES
1. Pandolfino JE, Kahrilas PJ. Presentation, diagnosis, and management 
of achalasia. Clin Gastroenterol Hepatol 2013;11:887-897.
2. Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis 
and management of achalasia. Am J Gastroenterol 2013;108:1238-1249.
3. Stavropoulos SN, Modayil R, Friedel D. Achalasia. Gastrointest En-
dosc Clin N Am 2013;23:53-75.
4. Richter JE. The diagnosis and misdiagnosis of achalasia: it does not 
have to be so difficult. Clin Gastroenterol Hepatol 2011;9:1010-1011.
5. Kessing BF, Bredenoord AJ, Smout AJ. Erroneous diagnosis of gastro-
esophageal reflux disease in achalasia. Clin Gastroenterol Hepatol 
2011;9:1020-1024.
6. Verlaan T, Rohof WO, Bredenoord AJ, Eberl S, Rösch T, Fockens P. 
Effect of peroral endoscopic myotomy on esophagogastric junction 
physiology in patients with achalasia. Gastrointest Endosc 2013;78:39-
44.
7. Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical 
treatments for achalasia: a systematic review and meta-analysis. Ann 
Surg 2009;249:45-57.
8. Lake JM, Wong RK. Review article: the management of achalasia: a 
comparison of different treatment modalities. Aliment Pharmacol 
Ther 2006;24:909-918.
9. Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of 
pneumatic dilatation and Heller myotomy for the treatment of achala-
sia. Clin Gastroenterol Hepatol 2006;4:580-587.
10. Vaezi MF, Richter JE. Diagnosis and management of achalasia. Ameri-
can College of Gastroenterology Practice Parameter Committee. Am J 
Gastroenterol 1999;94:3406-3412.
11. Zerbib F, Thétiot V, Richy F, Benajah DA, Message L, Lamouliatte H. 
Repeated pneumatic dilations as long-term maintenance therapy for 
esophageal achalasia. Am J Gastroenterol 2006;101:692-697.
12. Katzka DA, Castell DO. Review article: an analysis of the efficacy, per-
foration rates and methods used in pneumatic dilation for achalasia. 
Aliment Pharmacol Ther 2011;34:832-839.
13. Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dila-
tion versus laparoscopic Heller’s myotomy for idiopathic achalasia. N 
Engl J Med 2011;364:1807-1816.
14. Khashab MA, Kalloo AN. NOTES: current status and new horizons. 
Gastroenterology 2012;142:704-710.
15. Pasricha PJ, Hawari R, Ahmed I, et al. Submucosal endoscopic esoph-
ageal myotomy: a novel experimental approach for the treatment of 
achalasia. Endoscopy 2007;39:761-764.
16. Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy 
(POEM) for esophageal achalasia. Endoscopy 2010;42:265-271.
17. Teitelbaum EN, Hungness ES. Peroral endoscopic myotomy peripro-
cedural evaluation: predicting and measuring outcomes. Tech Gastro-
intest Endosc 2013;15:135-139.
18. Eckardt VF. Clinical presentations and complications of achalasia. 
Gastrointest Endosc Clin N Am 2001;11:281-292.
19. von Renteln D, Inoue H, Minami H, et al. Peroral endoscopic myoto-
my for the treatment of achalasia: a prospective single center study. 
Am J Gastroenterol 2012;107:411-417.
20. Sharata A, Kurian AA, Dunst CM, Bhayani NH, Reavis KM, Swanström 
LL. Peroral endoscopic myotomy (POEM) is safe and effective in the 
setting of prior endoscopic intervention. J Gastrointest Surg 2013;17: 
1188-1192.
21. Stavropoulos SN, Modayil R, Friedel D. Extended indications and 
contraindications for peroral endoscopic myotomy. Tech Gastrointest 
Endosc 2013;15:149-152.
22. Stavropoulos SN, Modayil RJ, Friedel D, Savides T. The International 
Per Oral Endoscopic Myotomy Survey (IPOEMS): a snapshot of the 
global POEM experience. Surg Endosc 2013;27:3322-3338.
23. Stavropoulos SN, Iqbal S, Modayil R, Dejesus D. Per oral endoscopic 
myotomy, equipment and technique: a step-by-step explanation. Vid-
eo J Encycl GI Endosc 2013;1:96-100.
24. Inoue H, Tianle KM, Ikeda H, et al. Peroral endoscopic myotomy for 
esophageal achalasia: technique, indication, and outcomes. Thorac 
Surg Clin 2011;21:519-525.
25. Hungness ES, Teitelbaum EN, Santos BF, et al. Comparison of periop-
erative outcomes between peroral esophageal myotomy (POEM) and 
laparoscopic Heller myotomy. J Gastrointest Surg 2013;17:228-235.
26. Leeuwenburgh I, Scholten P, Alderliesten J, et al. Long-term esophageal 
cancer risk in patients with primary achalasia: a prospective study. Am 
J Gastroenterol 2010;105:2144-2149.
27. Swanström LL, Rieder E, Dunst CM. A stepwise approach and early 
clinical experience in peroral endoscopic myotomy for the treatment of 
achalasia and esophageal motility disorders. J Am Coll Surg 2011;213: 
751-756.
28. Swanstrom LL, Kurian A, Dunst CM, Sharata A, Bhayani N, Rieder E. 
Long-term outcomes of an endoscopic myotomy for achalasia: the 
POEM procedure. Ann Surg 2012;256:659-667.
29. Zhou PH, Li QL, Yao LQ, et al. Peroral endoscopic remyotomy for 
failed Heller myotomy: a prospective single-center study. Endoscopy 
2013;45:161-166.
30. Li QL, Zhou PH, Yao LQ, et al. Early diagnosis and management of 
delayed bleeding in the submucosal tunnel after peroral endoscopic 
myotomy for achalasia (with video). Gastrointest Endosc 2013;78:370-
374.
31. Li H, Linghu E, Wang X. Fibrin sealant for closure of mucosal pene-
tration at the cardia during peroral endoscopic myotomy (POEM). 
Endoscopy 2012;44 Suppl 2 UCTN:E215-E216.
32. Saxena P, Chavez YH, Kord Valeshabad A, Kalloo AN, Khashab MA. 
An alternative method for mucosal flap closure during peroral endo-
scopic myotomy using an over-the-scope clipping device. Endoscopy 
2013;45:579-581.
33. Ling T, Pei Q, Pan J, et al. Successful use of a covered, retrievable stent to 
seal a ruptured mucosal flap safety valve during peroral endoscopic my-
otomy in a child with achalasia. Endoscopy 2013;45 Suppl 2 UCTN:E63-
E64.
34. Kurian AA, Bhayani NH, Reavis K, Dunst C, Swanström L. Endo-
scopic suture repair of full-thickness esophagotomy during per-oral 
esophageal myotomy for achalasia. Surg Endosc 2013;27:3910.
35. Familiari P, Marchese M, Boskoski I, Costamagna G. Peroral endoscop-
ic myotomy safety data. Tech Gastrointest Endosc 2013;15:144-148.
36. Chiu PW, Wu JC, Teoh AY, et al. Peroral endoscopic myotomy for treat-
ment of achalasia: from bench to bedside (with video). Gastrointest En-
dosc 2013;77:29-38.
37. Ren Z, Zhong Y, Zhou P, et al. Perioperative management and treat-
ment for complications during and after peroral endoscopic myotomy 
(POEM) for esophageal achalasia (EA) (data from 119 cases). Surg En-
dosc 2012;26:3267-3272.
38. Baldaque-Silva F, Marques M, Ramalho R, Vilas-Boas F, Afonso M, 
Macedo G. Case description of cap retention in the submucosal tunnel 
during peroral endoscopic myotomy. Am J Gastroenterol 2012;107:1586.
39. Kurian AA, Dunst CM, Sharata A, Bhayani NH, Reavis KM, Swanström 
LL. Peroral endoscopic esophageal myotomy: defining the learning 
curve. Gastrointest Endosc 2013;77:719-725.
40. Shiwaku H, Inoue H, Beppu R, et al. Successful treatment of diffuse 
esophageal spasm by peroral endoscopic myotomy. Gastrointest Endosc 
2013;77:149-150.
41. Yoshida A, Inoue H, Ikeda H, et al. Clinical results of POEM (per-oral 
endoscopic myotomy) for esophageal achalasia in 161 consecutive 
cases. Gastrointest Endosc 2012;75(4 Suppl):AB212.
42. Zhou PH, Yao L, Zhang YQ, et al. Per oral endoscopic myotomy 
(POEM) for esophageal achalasia: 205 cases report. Gastrointest En-
dosc 2012;75(4 Suppl):AB132-AB133.
Kumta NA et al.
  397
43. Maselli R, Inoue H, Misawa M, et al. Peroral endoscopic myotomy 
(POEM) in a 3-year-old girl with severe growth retardation, achalasia, 
and Down syndrome. Endoscopy 2012;44 Suppl 2 UCTN:E285-E287.
44. Onimaru M, Inoue H, Ikeda H, et al. Peroral endoscopic myotomy is 
a viable option for failed surgical esophagocardiomyotomy instead of 
redo surgical Heller myotomy: a single center prospective study. J Am 
Coll Surg 2013;217:598-605.
45. Khashab MA, Sharaiha RZ, Saxena P, et al. Novel technique of auto-
tunneling during peroral endoscopic myotomy (with video). Gastroin-
test Endosc 2013;77:119-122.
46. Eleftheriadis N, Inoue H, Ikeda H, et al. Training in peroral endo-
scopic myotomy (POEM) for esophageal achalasia. Ther Clin Risk 
Manag 2012;8:329-342.
47. Desilets DJ, Romanelli JR, Earle DB. Starting a peroral endoscopic my-
otomy program at your institution. Tech Gastrointest Endosc 2013;15: 
157-159.
48. Khashab MA. Thoughts on starting a peroral endoscopic myotomy 
program. Gastrointest Endosc 2013;77:109-110.
49. von Renteln D, Vassiliou MC, Rösch T. Training for peroral endoscopic 
myotomy. Tech Gastrointest Endosc 2013;15:153-156.
50. Rohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of 
treatment for patients with achalasia depends on the distensibility of 
the esophagogastric junction. Gastroenterology 2012;143:328-335.
51. Costamagna G, Marchese M, Familiari P, Tringali A, Inoue H, Perri V. 
Peroral endoscopic myotomy (POEM) for oesophageal achalasia: pre-
liminary results in humans. Dig Liver Dis 2012;44:827-832.
52. Von Renteln D, Fuchs KH, Fockens P, et al. Peroral endoscopic myot-
omy for the treatment of achalasia: an international prospective multi-
center study. Gastroenterology 2013;145:309-311.
53. Stavropoulos SN, Modayil RJ, Brathwaite CE, et al. POEM (per oral 
endoscopic myotomy): 3 year experience by a gastroenterologist at a 
US center. Still safe and effective even in patients with advanced age, 
severe achalasia and severe comorbidities. Gastrointest Endosc 2013; 
77(5 Suppl):AB459.
54. Lee BH, Shim KY, Hong SJ, et al. Peroral endoscopic myotomy for treat-
ment of achalasia: initial results of a Korean study. Clin Endosc 2013; 
46:161-167.
55. Minami H, Isomoto H, Yamaguchi N, et al. Peroral endoscopic myot-
omy for esophageal achalasia: clinical impact of 28 cases. Dig Endosc 
2014;26:43-51.
